HIGHLIGHTS
- who: Chenxi Hu and collaborators from the Department of Immunology, School of Basic Medicine, Hebei Medical University, Zhongshan East Rd, The First Hospital of Hebei Medical University, Shijiazhuang, China have published the research work: Multifaceted Roles of the N6-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment, in the Journal: Biomolecules 2022, 1042 of /2022/
- what: Cancer cells utilize METTL3 to exploit specific molecular pathways to favor proliferation, metastasis, invasion, drug resistance, and the maintenance of cancer progenitor cells (see Table 1).
- how: MeRIP-seq results showed that SOX2 is the downstream . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.